Long-term sequelae following previous coronavirus epidemics

Oliver O'Sullivan, Oliver O'Sullivan

Abstract

Before the current pandemic, there had been two global epidemics from major coronavirus outbreaks since the turn of the century: severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Both epidemics left survivors with fatigue, persistent shortness of breath, reduced quality of life and a significant burden of mental health problems.It is likely that some of the chronic problems encountered by survivors of SARS and MERS may be relevant for medical planning of the services required for survivors of coronavirus disease 2019 (COVID-19) caused by the novel coronavirus SARS-CoV-2. Given the similarities between the diseases, the recovery and rehabilitation of the survivors of COVID-19 is likely to be focused around cardiopulmonary sequelae, fatigue and the psychological burden of COVID-19, but in a much larger population.

Keywords: COVID-19; Coronavirus; rehab; rehabilitation.

© Royal College of Physicians 2021. All rights reserved.

References

    1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497–506.
    1. Yu F, Du L, Ojcius DM, et al. Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China. Microbes Infect 2020;22:74–9.
    1. Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395:565–74.
    1. Coraci D, Fusco A, Frizziero A, et al. Global approaches for global challenges: The possible support of rehabilitation in the management of COVID-19. J Med Virol 2020, in press ( 10.1002/jmv.25829).
    1. Koh GC-H, Hoenig H. How should the rehabilitation community prepare for 2019-nCoV? Arch Phys Med Rehab 2020;101:1068–71.
    1. Hui DSC, Chan MCH, Wu AK, Ng PC. Severe acute respiratory syndrome (SARS): epidemiology and clinical features. Postgrad Med J 2004;80:373–81.
    1. Chan-Yeung M, Xu R. SARS: epidemiology. Respirology 2003;8:S9–S14.
    1. Tansey C, Louie M, Loeb M, et al. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch Intern Med 2007;167:1312–20.
    1. Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003;348:1986–94.
    1. Tsai LK, Hsieh ST, Chao CC, et al. Neuromuscular disorders in severe acute respiratory syndrome. Arch Neurol. 2004;61:1669–73.
    1. Zhang P, Li J, Liu H, et al. Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15 year follow-up from a prospective cohort study. Bone Research 2020;8:8.
    1. Ngai JC, Ko FW, Ng SS, et al. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology 2010;15:543–50.
    1. Yu CCW, Li AM, So RCH, et al. Longer term follow up of aerobic capacity in children affected by severe acute respiratory syndrome (SARS). Thorax 2006;61:240–6.
    1. Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol 2011;11:37.
    1. Chan KS, Zheng JP, Mok YW, et al. SARS: Prognosis, outcome and sequelae. Respirology 2003;8:S36–S40.
    1. Gardner PJ, Moallef P. Psychological impact on SARS survivors: Critical review of the English language literature. CMAJ 2015:56;123–35.
    1. Lau MC, Ng YF, Jones YM, et al. A randomised controlled trial of the effectiveness of an exercise training program in patients recovering from severe acute respiratory syndrome. Aus J Physio 2005;51:213–9.
    1. World Health Organization Middle East respiratory coronavirus (MERS-CoV) – The Kingdom of Saudi Arabia. [Accessed 10 April 2020].
    1. Elkholy AA, Grant R, Assiri A, et al. MERS-CoV infection among healthcare workers and risk factors for death: Retrospective analysis of all laboratory-confirmed cases reported to WHO from 2012 to 2 June 2018. J Infect Pub Health 2020;13:418–22.
    1. Garbati MA, Shamsudeen FF, Fang VJ, et al. A comparative study of clinical presentation and risk factors for adverse outcome in patients hospitalised with acute respiratory disease due to MERS coronavirus or other causes. PLoS One 2016;11:e0165978.
    1. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 2013;13:752–61.
    1. White J. Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV). Clin Mic News 2014;36:115–22.
    1. Batawi S, Tarazan N, Al-Raddadi R, et al. Quality of life reported by survivors after hospitalization for Middle East respiratory syndrome (MERS). Health Qual Life Outcomes 2019;17:101.
    1. Lee SH, Shin HS, Park HY, et al. Depression as a mediator of chronic fatigue and post-traumatic stress symptoms in Middle East respiratory syndrome survivors. Psychiatry Investig 2019;16:59–64.
    1. Jung H, Jung SY, Lee MH, et al. Assessing the presence of post-traumatic stress and turnover intention among nurses post–middle east respiratory syndrome outbreak: the importance of supervisor support. Workplace Health Saf 2020;68:337–45.
    1. Herridge MS, Cheung AM, Tansey CM, et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003;348:683–93.
    1. Herridge MS, Tansey CM, Matté A, et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med 2011;364:1293.
    1. Mikkelsen M, Netzer G, Iwashyna T. Post intensive care syndrome (PICS). [Accessed 5 May 2020].

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel